[ Price : $8.95]
FDA clears a new indication for neurocare groups Apollo TMS therapy device to treat adolescents with major depressive disorder.[ Price : $8.95]
FDA approves a Johnson & Johnson NDA for Inlexzo (gemcitabine intravesical system) for adults with non-muscle invasive bladder can...[ Price : $8.95]
FDA grants Greenwich LifeSciences fast track status for GLSI-100 for preventing breast cancer recurrences.[ Price : $8.95]
In a new crackdown on drug advertising, FDA orders pharmaceutical companies to remove any noncompliant ads and bring all promotion...[ Price : $8.95]
Former FDA Digital Health Center of Excellence acting director Sonja Fulmer leaves the agency to accept a position at Mayo Clinic ...[ Price : $8.95]
Lexicon Pharmaceuticals submits new clinical data to FDA that attempts to advance its stalled NDA for its diabetes drug Zynquist (...[ Price : $8.95]
Capricor Therapeutics posts its response to an FDA complete response letter for Bytreldo since the agency published the letter pub...[ Price : $8.95]
NRx Pharmaceuticals petitions FDA seeking a ban on all ketamine products formulated with the preservative benzethonium chloride, a...